Houlihan Lokey, Inc. (NYSE:HLI) is Barlow Wealth Partners Inc.’s 3rd Largest Position

Barlow Wealth Partners Inc. lifted its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 1.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 180,345 shares of the financial services provider’s stock after purchasing an additional 3,164 shares during the period. Houlihan Lokey comprises approximately 3.8% of Barlow Wealth Partners Inc.’s holdings, making the stock its 3rd biggest holding. Barlow Wealth Partners Inc. owned 0.26% of Houlihan Lokey worth $29,001,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Opal Wealth Advisors LLC purchased a new position in shares of Houlihan Lokey during the 2nd quarter worth approximately $26,000. Crewe Advisors LLC boosted its position in Houlihan Lokey by 264.5% during the second quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 164 shares during the last quarter. Ashton Thomas Private Wealth LLC acquired a new stake in Houlihan Lokey during the second quarter worth approximately $38,000. Accent Capital Management LLC acquired a new stake in Houlihan Lokey during the fourth quarter worth approximately $42,000. Finally, Benjamin F. Edwards & Company Inc. boosted its position in Houlihan Lokey by 194.9% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 401 shares of the financial services provider’s stock worth $52,000 after acquiring an additional 265 shares during the last quarter. 78.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. JPMorgan Chase & Co. decreased their price target on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating on the stock in a report on Wednesday, July 31st. Morgan Stanley lifted their price target on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an “equal weight” rating in a report on Monday, September 23rd. Wells Fargo & Company assumed coverage on shares of Houlihan Lokey in a report on Thursday, September 12th. They issued an “underweight” rating and a $149.00 price target on the stock. UBS Group lifted their price target on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a report on Tuesday. Finally, Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $154.00 price target (up previously from $139.00) on shares of Houlihan Lokey in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $157.00.

Insider Activity at Houlihan Lokey

In related news, General Counsel Christopher M. Crain sold 1,000 shares of Houlihan Lokey stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total transaction of $155,290.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, General Counsel Christopher M. Crain sold 1,000 shares of Houlihan Lokey stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total transaction of $155,290.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Gillian Beth Zucker sold 200 shares of Houlihan Lokey stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $152.49, for a total transaction of $30,498.00. Following the sale, the director now directly owns 7,001 shares in the company, valued at $1,067,582.49. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,717 shares of company stock worth $1,479,513. 25.97% of the stock is currently owned by corporate insiders.

Houlihan Lokey Stock Performance

Shares of NYSE:HLI traded up $1.11 during midday trading on Wednesday, hitting $164.96. 24,140 shares of the company’s stock traded hands, compared to its average volume of 321,802. The company has a market cap of $11.31 billion, a PE ratio of 39.87 and a beta of 0.66. The firm’s fifty day moving average price is $153.95 and its two-hundred day moving average price is $140.61. Houlihan Lokey, Inc. has a twelve month low of $94.67 and a twelve month high of $165.42.

Houlihan Lokey (NYSE:HLI) last posted its earnings results on Tuesday, July 30th. The financial services provider reported $1.22 earnings per share for the quarter, meeting the consensus estimate of $1.22. The business had revenue of $514.00 million for the quarter, compared to analyst estimates of $508.70 million. Houlihan Lokey had a net margin of 15.30% and a return on equity of 18.80%. The business’s quarterly revenue was up 23.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.89 EPS. As a group, equities research analysts anticipate that Houlihan Lokey, Inc. will post 5.54 EPS for the current fiscal year.

Houlihan Lokey Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Sunday, September 15th. Investors of record on Tuesday, September 3rd were issued a dividend of $0.57 per share. The ex-dividend date of this dividend was Tuesday, September 3rd. This represents a $2.28 annualized dividend and a dividend yield of 1.38%. Houlihan Lokey’s payout ratio is 55.47%.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.